134 related articles for article (PubMed ID: 25315250)
1. Chipping away at major depressive disorder.
Rucker JJ; McGuffin P
Genome Biol; 2014 Jul; 15(7):421. PubMed ID: 25315250
[TBL] [Abstract][Full Text] [Related]
2. MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4.
Li J; Meng H; Cao W; Qiu T
Neurosci Lett; 2015 Oct; 606():167-72. PubMed ID: 26314506
[TBL] [Abstract][Full Text] [Related]
3. MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1.
Wang X; Wang B; Zhao J; Liu C; Qu X; Li Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30482883
[TBL] [Abstract][Full Text] [Related]
4. microRNA-124: a putative therapeutic target and biomarker for major depression.
Dwivedi Y
Expert Opin Ther Targets; 2017 Jul; 21(7):653-656. PubMed ID: 28490207
[No Abstract] [Full Text] [Related]
5. NLRP3 inflammasome: a new target in major depressive disorder.
Alcocer-Gómez E; Cordero MD
CNS Neurosci Ther; 2014 Mar; 20(3):294-5. PubMed ID: 24479787
[No Abstract] [Full Text] [Related]
6. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
[TBL] [Abstract][Full Text] [Related]
7. Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
Mamdani F; Berlim MT; Beaulieu MM; Labbe A; Merette C; Turecki G
Transl Psychiatry; 2011 Jun; 1(6):e13. PubMed ID: 22832429
[TBL] [Abstract][Full Text] [Related]
8. Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.
Feyissa AM; Woolverton WL; Miguel-Hidalgo JJ; Wang Z; Kyle PB; Hasler G; Stockmeier CA; Iyo AH; Karolewicz B
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):279-83. PubMed ID: 19945495
[TBL] [Abstract][Full Text] [Related]
9. Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depression.
Dressman BA; Tromiczak EG; Chappell MD; Tripp AE; Quimby SJ; Vetman T; Fivush AM; Matt J; Jaramillo C; Li R; Khilevich A; Blanco MJ; Smith SC; Carpintero M; de Diego JE; Barberis M; García-Cerrada S; Soriano JF; Schkeryantz JM; Witkin JM; Wafford KA; Seidel W; Britton T; Overshiner CD; Li X; Wang XS; Heinz BA; Catlow JT; Swanson S; Bedwell D; Ornstein PL; Mitch CH
Bioorg Med Chem Lett; 2016 Dec; 26(23):5663-5668. PubMed ID: 27836401
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro.
Wei YB; Melas PA; Villaescusa JC; Liu JJ; Xu N; Christiansen SH; Elbrønd-Bek H; Woldbye DP; Wegener G; Mathé AA; Lavebratt C
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27507301
[TBL] [Abstract][Full Text] [Related]
11. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
Chaki S; Fukumoto K
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
Wohleb ES; Gerhard D; Thomas A; Duman RS
Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
[TBL] [Abstract][Full Text] [Related]
13. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.
Lopez JP; Lim R; Cruceanu C; Crapper L; Fasano C; Labonte B; Maussion G; Yang JP; Yerko V; Vigneault E; El Mestikawy S; Mechawar N; Pavlidis P; Turecki G
Nat Med; 2014 Jul; 20(7):764-8. PubMed ID: 24908571
[TBL] [Abstract][Full Text] [Related]
14. Molecular neurobiology of major depressive disorder.
Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():275-6. PubMed ID: 26169576
[No Abstract] [Full Text] [Related]
15. The role of mTOR in depression and antidepressant responses.
Abelaira HM; Réus GZ; Neotti MV; Quevedo J
Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
[TBL] [Abstract][Full Text] [Related]
16. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
[TBL] [Abstract][Full Text] [Related]
17. ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder.
Milanesi E; Minelli A; Cattane N; Cattaneo A; Mora C; Barbon A; Mallei A; Popoli M; Florio V; Conca A; Bignotti S; Gennarelli M
BMC Psychiatry; 2012 Sep; 12():145. PubMed ID: 22989054
[TBL] [Abstract][Full Text] [Related]
18. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
[TBL] [Abstract][Full Text] [Related]
20. Role of Complex Epigenetic Switching in Tumor Necrosis Factor-α Upregulation in the Prefrontal Cortex of Suicide Subjects.
Wang Q; Roy B; Turecki G; Shelton RC; Dwivedi Y
Am J Psychiatry; 2018 Mar; 175(3):262-274. PubMed ID: 29361849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
